Clinical Trial Announcement
Your Participation Matters
We’re excited to announce a clinical trial aimed to investigate the treatment of patients with Long COVID/Post-Acute Sequelae of COVID (PASC) with Selzentry (maraviroc) tablets and Lipitor (atorvastatin) tablets. The clinical trial will support a New Drug Application (NDA) filing through the 505(B)(2) pathway of the Federal Food, Drug, and Cosmetic Act (FDCA). Your involvement could contribute to groundbreaking discoveries and improved treatments for many suffering from the effects of Long Covid. If you're interested in learning more or signing up, please fill out the form below and one of our team members will get in touch with you.
This is not an informed consent to be in the trial. You will be contacted to learn more about your interest and how you might be able to be considered for the trial once it begins recruitment.
Country
*
FULL NAME
*
First Name
Last Name
EMAIL
*
example@example.com
PHONE NUMBER
-
Country Code
-
Area Code
Phone Number
I AM A...
*
Please Select
PATIENT
MEDICAL PROFESSIONAL
INVESTOR
MEDIA
SUBMIT
Should be Empty: